Can you have sedation if you take a GLP-1 medication?
Taking a GLP-1 medication does not, on its own, rule out IV sedation or general anaesthesia for wisdom tooth removal. It does change how the anaesthetic is planned, because these drugs slow the rate at which the stomach empties, and an anaesthetic depends on the stomach being empty. The decision is made for you individually, using your dose, how long you have been on it, any stomach symptoms, and your reason for taking it.
The drugs in question are glucagon-like peptide-1 receptor agonists and the newer combined agents that act on the same pathway. Semaglutide is sold as Ozempic and Wegovy as a weekly injection and as Rybelsus as a daily tablet. Tirzepatide is sold as Mounjaro and Zepbound. Liraglutide is sold as Victoza and Saxenda, and dulaglutide as Trulicity. The brand names appear here only so that you can recognise what you take; the question that matters is the class, not the brand.
Many people now receive these medicines from a telehealth service or a compounding pharmacy rather than from their usual doctor, and some take them only for weight. Those routes do not change the pharmacology. A compounded semaglutide injection from an online clinic slows the stomach in the same way a pen from a retail pharmacy does, and it belongs on your medication list in exactly the same way.

How a slow stomach becomes an anaesthetic problem
Part of how GLP-1 medicines work is by slowing gastric emptying. Food leaves the stomach more gradually, which is one reason people on them feel full sooner and for longer. That effect is useful for appetite and blood sugar. It is a problem for anaesthesia, because every fasting rule in anaesthesia was written on the assumption that a stomach empties at a roughly normal rate.
Fasting before sedation exists for one reason. Sedative and anaesthetic drugs reduce the protective reflexes that normally stop stomach contents from reaching the lungs: the cough, the swallow and the tone of the muscle at the top of the stomach. If something comes back up while those reflexes are dulled, it can be breathed into the airway. That event is called pulmonary aspiration, and it can cause pneumonia or an acute lung injury. It is uncommon, and fasting is how it is kept uncommon.
The standard fasting intervals assume that a light meal has left the stomach after a set number of hours. Case reports and imaging studies of patients on GLP-1 medicines have found solid food still present in the stomach after a fast that would normally have cleared it. That is the whole concern in one sentence: a patient can follow the fasting instructions exactly and still arrive with a stomach that is not empty.
Third molar surgery adds a local factor. The operation is in the mouth, at the entrance to the airway, and office anaesthesia for wisdom teeth is commonly delivered without a breathing tube in the windpipe. The airway is protected by positioning, suction, a throat pack and the people watching it, not by a sealed tube. That works very well for a patient whose stomach is empty. It is the reason a full stomach is taken seriously in this setting rather than waved through.
What the evidence does not show is just as important. Much of what is published is case reports, retrospective database studies and ultrasound studies of gastric contents, and they do not all agree on how large the added risk is. Some data suggest the slowing effect lessens with long-term use. None of that makes the concern go away; it means the honest description is an uncertain but plausible risk, which is exactly the situation in which anaesthesia societies ask for individual assessment rather than a single rule.
What the anaesthesia guidance says
There is no blanket rule that everyone must stop a GLP-1 medication before anaesthesia. Guidance published in 2024 by the American Society of Anesthesiologists together with gastroenterology, bariatric surgery and perioperative care societies says most patients can continue these medicines, and that the decision should be individualised and made jointly by the patient, the prescriber and the procedural team. Whether to stop is never the patient's call alone.
The position has moved, which is part of why patients hear conflicting advice. In 2023 the American Society of Anesthesiologists issued consensus guidance that leaned toward withholding these medicines before elective procedures. As more patients came through operating rooms and endoscopy suites on them, and as the risks of interrupting treatment became clearer, the 2024 multi-society guidance moved toward continuing the medicine for most people and managing the stomach risk in other ways. You can read the society's own patient material at asahq.org.
In outline, the 2024 guidance does four things. It identifies which patients are likely to be at higher risk of retained stomach contents. It suggests that a liquid diet for about a day before the procedure may be considered for those continuing the medicine. It asks the team to check on the day for stomach symptoms and to consider postponing, or changing the anaesthetic approach, if they are present. And it says that if the medicine is to be held in a particular case, that decision is made with the prescriber, not by the patient on their own.
The guidance is described by its authors as consensus based, because the evidence base is limited. It is a framework for a conversation, not a set of instructions a patient can apply at home. That is why this page does not quote hold periods or diet durations as things to do: the right answer for a weekly injection at a high dose in someone with nausea is not the right answer for a stable daily tablet in someone with no symptoms.
The U.S. Food and Drug Administration has also acted. The prescribing information for medicines in this class now includes a warning about pulmonary aspiration during general anaesthesia or deep sedation, and advises that patients tell their healthcare providers they take the medicine before any planned procedure. The current label for your product is available through the drug information pages at fda.gov, and your pharmacist can show you the relevant section.

Who is likely to be at higher risk
Not every patient on a GLP-1 medicine carries the same risk. The 2024 guidance and the studies behind it point to a handful of features that make retained stomach contents more likely. None of these is a reason to cancel on its own; each is a reason for the team to know about it early enough to plan.
| Feature | Why it matters | What the team may consider |
|---|---|---|
| Recently started, or the dose was increased in recent weeks | The slowing of the stomach and the nausea that comes with it tend to be most marked during dose escalation | Asking the prescriber whether the surgery date and the escalation schedule fit together, and planning the diet beforehand |
| Weekly injection rather than a daily tablet | A weekly drug stays in the body for days, so its effect cannot be timed around a single dose | Discussing the timing of the last dose with the prescriber well before the surgery date |
| Nausea, vomiting, bloating, abdominal pain or constipation | Ongoing stomach symptoms suggest emptying is slowed at that moment | Postponing the case, or changing the anaesthetic approach, if symptoms are present on the day |
| Diabetes with known gastroparesis or long-standing nerve complications | Diabetes itself can slow the stomach, and the effects can add together | A more cautious plan, and sometimes a recommendation that the case be done in a hospital |
| Other medicines that slow the gut, such as regular opioids | Two causes of slow emptying in one patient compound the risk | Reviewing the full medication list together rather than one drug at a time |
| Medicine stopped recently, or doses missed | The team needs to know what is actually in your system, not what is on the prescription | Recording the real date of the last dose, and checking blood sugar on arrival if you have diabetes |
Some hospitals and surgical centres use a bedside ultrasound of the stomach to look for retained contents before an anaesthetic. The 2024 guidance mentions it as an option where it is available and the team is trained in it. It is not universally available in office settings, and its absence is one reason why the history you give, and the symptoms you report, carry so much weight.
The liquid diet the day before
The 2024 multi-society guidance suggests that, for patients who continue a GLP-1 medicine, a liquid diet for roughly the day before the procedure may be considered, so that there is less solid food in a slow stomach to begin with. It is a suggestion for the team to apply case by case, and the instructions you follow should be the specific written ones the surgical office gives you, not a general description.
The reasoning is simple. Liquids leave the stomach faster than solids, including in a stomach that has been slowed. If the last solid meal is a full day before the anaesthetic rather than the evening before, there is more time for it to clear. The liquid diet sits on top of the normal fasting rules; it does not replace them. The usual final cut off for food and drink on the morning of surgery still applies, and our page on fasting rules explains why those intervals exist.
What counts as allowed, for how long, and whether the diet applies to you at all are details that vary with your medicine, your dose and your health. A person with diabetes on insulin as well as a GLP-1 medicine, for example, cannot simply switch to liquids without a plan for blood sugar. That is a conversation that needs to happen days in advance, which is one of the strongest practical reasons to mention the medicine when you book rather than on the morning.

Why you need to tell us at booking and again on the day
Yes. Tell the surgical office that you take a GLP-1 medicine when you book, and tell the team again on the morning of surgery. The first disclosure gives enough time to talk to your prescriber, plan any diet change and choose the right appointment. The second tells the team what has actually happened since: when you last took it, whether you have stomach symptoms, and what you last ate.
Patients leave these medicines off their list for understandable reasons. Some think of a weekly injection as something other than a daily medication. Some take it for weight and do not regard it as treatment for a condition. Some started it through a telehealth service after their last visit to a doctor. Some feel self-conscious about it. None of those reasons changes what the drug does to the stomach, and the team cannot plan around something they have not been told.
What to tell the office when you book
- The name of the medicine, whether it is a brand product or compounded, and who prescribes it
- Whether it is a weekly injection or a daily tablet or injection, and your current dose
- When you started it and when the dose was last increased, or whether an increase is planned
- Why you take it: type 2 diabetes, weight, or another reason
- Any nausea, vomiting, reflux, bloating, early fullness or constipation in recent weeks
- Any other medicines for diabetes, including insulin, and any regular opioid pain medicine
What to tell the team on the day
- The date and time of your last dose, as it actually happened
- What you last ate and drank, and when, without rounding to the answer you think is expected
- Whether you feel sick, bloated or full, or have vomited since the day before
- Whether anything changed in your prescriber's instructions since you booked
Being exact about the last meal matters more for patients on these medicines than for anyone else. If you ate something later than the instructions allowed, say so. The team is not judging you; they are deciding whether it is reasonable to give an anaesthetic that will take away your ability to protect your own airway.
What happens on the day, and why a case may not go ahead
On the morning of surgery the team reviews your medicine, your last dose, your fasting and any symptoms before anything is given. If the picture is reassuring, the anaesthetic usually goes ahead as planned. If it is not, the responsible decision is to change the plan, and nobody can promise in advance which way that review will go.
There are several possible outcomes, and patients should know about all of them before the day. The case may proceed as planned. The anaesthetic approach may be adjusted, for example by using a lighter level of sedation. The operation may be done under local anaesthetic alone, with you awake and able to protect your own airway, if that suits the teeth involved and you are comfortable with it. The case may be postponed to another day with a revised plan. Occasionally the recommendation will be that the surgery is done in a hospital, where the airway can be secured with a breathing tube.
A postponement is frustrating, especially if you have arranged a day off and an escort. It is still the right result when the stomach may not be empty. Aspiration under anaesthesia is a serious complication for an operation that, in most cases, can wait a week or two without harm. If your wisdom teeth are causing acute infection or swelling, the urgency changes, and that is a conversation to have directly with the surgeon.
Local anaesthetic alone deserves a fair mention because it is often overlooked. Many third molars can be removed with numbing alone, and an awake patient keeps every protective reflex. It is not suitable for everyone, particularly for deeply impacted teeth or very anxious patients, but for some people on GLP-1 medicines it removes the stomach question entirely. You can ask about it.
Why stopping on your own is the wrong fix
It can seem obvious that the simplest solution is to skip a dose or two before surgery. It is not a decision a patient should make alone, and the guidance is explicit that any hold is decided with the prescriber. There are good reasons for that.
For people with type 2 diabetes, these medicines are glucose control. Stopping can raise blood sugar in the days around surgery, and raised glucose is associated with slower healing and a higher infection risk in surgical wounds. For people taking the medicine for weight, an unplanned interruption can bring back appetite quickly. For both groups, restarting after a gap can bring back the nausea and vomiting that often occur when treatment begins, and the prescriber may want to manage that restart rather than have you resume your usual dose.
There is also a timing problem. Weekly medicines remain active for days after the last injection, so skipping the dose closest to surgery does not necessarily mean the stomach is back to normal on the day. A patient who stops on their own and then reports it as if they had planned it with their doctor can leave the team with a false sense of security. The useful thing to do is the opposite: tell everyone the truth and let the prescriber and the surgical team agree the plan.

Who this page does not settle
This page describes a general framework. It does not settle the plan for anyone with complex medical problems on top of a GLP-1 medicine, such as advanced kidney disease, severe heart disease, a history of bariatric surgery, or poorly controlled diabetes. Those situations call for direct discussion between your own physicians and the surgeon, and some of them point toward a hospital setting from the start.
It also does not cover every drug that slows the stomach. Opioids, some antidepressants, some medicines for Parkinson disease and others can have similar effects, which is why the full medication list matters and not just the GLP-1 line. Our page on sedation when you take daily medication goes through the other common classes. If you have asthma or other breathing conditions as well, the airway question has another layer, covered in our page on asthma and office sedation.
Finally, guidance in this area has already changed once in two years and may change again as better evidence arrives. The surgical team works from the current position of the anaesthesia societies and the current prescribing information, which is another reason to rely on the instructions you receive for your own case rather than on anything written for the general public, this page included.
